Cryo-Cell International (NYSEAMERICAN:CCEL) Price Target Lowered to $8.50 at Maxim Group

Cryo-Cell International (NYSEAMERICAN:CCEL) had its price target reduced by Maxim Group from $9.00 to $8.50 in a report released on Tuesday,Benzinga reports. Maxim Group currently has a buy rating on the stock.

Cryo-Cell International Trading Down 1.8 %

Shares of NYSEAMERICAN:CCEL opened at $6.60 on Tuesday. Cryo-Cell International has a 1-year low of $5.12 and a 1-year high of $9.50. The company has a market cap of $53.20 million, a PE ratio of -6.23 and a beta of 0.53.

Cryo-Cell International Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 15.15%. The ex-dividend date was Friday, February 14th. Cryo-Cell International’s dividend payout ratio is -94.34%.

Institutional Trading of Cryo-Cell International

Institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC boosted its stake in Cryo-Cell International by 68.5% in the third quarter. Geode Capital Management LLC now owns 39,860 shares of the company’s stock worth $254,000 after purchasing an additional 16,203 shares in the last quarter. Rowlandmiller & PARTNERS.ADV acquired a new position in Cryo-Cell International in the fourth quarter worth $107,000. Northern Trust Corp boosted its stake in Cryo-Cell International by 78.2% in the fourth quarter. Northern Trust Corp now owns 38,902 shares of the company’s stock worth $288,000 after purchasing an additional 17,066 shares in the last quarter. Topline Capital Management LLC acquired a new position in Cryo-Cell International in the fourth quarter worth $354,000. Finally, CreativeOne Wealth LLC acquired a new position in Cryo-Cell International in the fourth quarter worth $113,000. Institutional investors and hedge funds own 10.44% of the company’s stock.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.